A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

Investigator Site, Caba

Investigator Site, San Juan

Investigator Site, New York

Investigator Site, New York

Investigator Site, Smithtown

Investigator Site, Syracuse

Investigator Site, Pittsburgh

Investigator Site, Cumberland

Investigator Site, Raleigh

Investigator Site, Charlotte

Investigator Site, Stockbridge

Investigator Site, Atlanta

Investigator Site, Orlando

Investigator Site, Aventura

Investigator Site, Clearwater

Investigator Site, Pinellas Park

Investigator Site, Birmingham

Investigator Site, Jackson

Investigator Site, Louisville

Investigator Site, Lansing

Investigator Site, Houston

Investigator Site, Austin

Investigator Site, Phoenix

Investigator Site, Glendale

Investigator Site, Tucson

Investigator Site, Los Angeles

Investigator Site, La Palma

Investigator Site, Artesia

Investigator Site, Upland

Investigator Site, La Jolla

Investigator Site, Caba

Investigator Site, Ciudad Autónoma de Buenos Aire

Investigator Site, Córdoba

Investigator Site, San Miguel de Tucumán

Investigator Site 1, Santiago

Investigator Site 2, Santiago

Investigator Site, Prague

Investigator Site, Berlin

Investigator Site, Dresden

Investigator Site, Mainz

Investigator Site, Mannheim

Investigator Site 1, Budapest

Investigator Site 2, Budapest

Investigator Site, Debrecen

Investigator Site, Gyula

Investigator Site, Zalaegerszeg

Investigator Site 1, Guadalajara

Investigator Site 2, Guadalajara

Investigator Site 3, Guadalajara

Investigator Site, Mexicali

Investigator Site, Mexico City

Investigator Site, Mérida

Investigator Site, San Luis Potosí City

Investigator Site 1, Lima

Investigator Site 2, Lima

Investigator Site 3, Lima

Investigator Site 4, Lima

Investigator Site 1, Cebu City

Investigator Site 2, Cebu City

Investigator Site, Lipa City

Investigator Site, Makati City

Investigator Site, Manila

Investigator Site, Quezon City

Investigator Site, Bydgoszcz

Investigator Site, Katowice

Investigator Site 1, Lodz

Investigator Site 2, Lodz

Investigator Site 1, Poznan

Investigator Site 2, Poznan

Investigator Site, Szczecin

Investigator Site, Almada

Investigator Site, Amadora

Investigator Site, Lisbon

Investigator Site, Ponte de Lima

Investigator Site, Porto

Investigator Site, Kazan'

Investigator Site, Kemerovo

Investigator Site, Orenburg

Investigator Site, Ryazan

Investigator Site 1, Saint Petersburg

Investigator Site 2, Saint Petersburg

Investigator Site, Smolensk

Investigator Site, Vladimir

Investigator Site, Voronezh

Investigator Site 1, Belgrade

Investigator Site 2, Belgrade

Investigator Site 3, Belgrade

Investigator Site 4, Belgrade

Investigator Site 5, Belgrade

Investigator Site, Niška Banja

Investigator Site, Daegu

Investigator Site, Gwangju

Investigator Site 1, Seoul

Investigator Site 2, Seoul

Investigator Site, A Coruña

Investigator Site 1, Barcelona

Investigator Site 2, Barcelona

Investigator Site 3, Barcelona

Investigator Site, Bilbao

Investigator Site 1, Madrid

Investigator Site 2, Madrid

Investigator Site, Sant Joan Despí

Investigator Site, Kaohsiung City

Investigator Site 1, Taichung

Investigator Site 2, Taichung

Investigator Site, Taipei

Investigator Site, Taoyuan District

Investigator Site, Ivano-Frankivsk

Investigator Site, Kharkiv

Investigator Site, Kryvyi Rih

Investigator Site 1, Kyiv

Investigator Site 2, Kyiv

Investigator Site 3, Kyiv

Investigator Site, Lviv

Investigator Site 1, Poltava

Investigator Site 2, Poltava

Investigator Site 1, Vinnytsia

Investigator Site 2, Vinnytsia